Advertisement
trendingPhotosenglish2387022https://zeenews.india.com/photos/india/zydus-cadilas-zycov-d-the-needle-free-covid-19-vaccine-for-adults-and-kids-all-you-need-to-know-2387022
photoDetails

Zydus Cadila's ZyCoV-D - the needle-free COVID-19 vaccine for adults and kids - all you need to know

Zydus Cadila in July had said that ZyCoV-D was effective against the new mutants of COVID-19, especially the Delta variant.

ZyCoV-D has shown efficacy rate of 66.6%

1/7
ZyCoV-D has shown efficacy rate of 66.6%

Zydus Cadila had applied for the emergency use authorization of ZyCoV-D in July. It was based on an efficacy rate of 66.6% in a late-stage trial of over 28,000 volunteers nationwide. This has been reportedly the largest COVID-19 vaccine trial so far in India. 

 

(Photo: Zydus Cadila)

ZyCoV-D is a three dose coronavirus vaccine

2/7
ZyCoV-D is a three dose coronavirus vaccine

ZyCoV-D is a three dose coronavirus vaccine that will be administered first on day zero, then on day 28th and on the 56th day.

 

(Photo: Zydus Cadila)

ZyCoV-D is a needle-free COVID-19 vaccine

3/7
ZyCoV-D is a needle-free COVID-19 vaccine

ZyCoV-D is a needle-free COVID-19 vaccine which is administered using The PharmaJet, a needle-free applicator, which ensures painless intradermal vaccine delivery. This will majorly help in administering the vaccine to kids.

 

(Photo: IANS)

ZyCoV-D is a Plasmid DNA vaccine

4/7
ZyCoV-D is a Plasmid DNA vaccine

Being a Plasmid DNA vaccine, ZyCoV-D doesn't have any problem associated with vector-based immunity. The Plasmid DNA platform also allows generating new constructs quickly to deal with mutations in the virus.

 

(Representational Photo: Pixabay)

ZyCoV-D is stored at 2-8 degrees C

5/7
ZyCoV-D is stored at 2-8 degrees C

ZyCoV-D is stored at 2-8 degrees C and has shown good stability at temperatures of 25 degrees C for at least three months. 

 

(Photo: Zydus Cadila)

Zydus Cadila planning to manufacture 10-12 crore vaccine doses every year

6/7
Zydus Cadila planning to manufacture 10-12 crore vaccine doses every year

As per Zydus Cadila, the firm is planning to manufacture 10-12 crore vaccine doses of ZyCoV-D annually. 

ZyCoV-D is the second home-grown shot

7/7
ZyCoV-D is the second home-grown shot

Zydus Cadila's coronavirus vaccine is the second home-grown shot to get emergency authorization in India after Bharat Biotech's Covaxin. It is developed in partnership with the Department of Biotechnology.

 

ZyCoV-D has also become the sixth COVID-19 vaccine to get approval in India.

 

(Representational Photo: ANI)

NEWS ON ONE CLICK